Aspen Aerogels (NYSE:ASPN) Stock Price Crosses Below 200 Day Moving Average - Should You Sell?

Aspen Aerogels logo with Materials background
Image from MarketBeat Media, LLC.

Key Points

  • Aspen Aerogels shares fell below their 200-day moving average, trading as low as $4.43 versus the $4.79 average and last changing hands at $4.475.
  • Analysts’ consensus rating is Hold, with an average price target of $6.25; ratings are split among three Buys, one Hold, and two Sells.
  • The company beat quarterly earnings and revenue estimates, reporting EPS of $0.11 and revenue of $85.18 million. Separately, major shareholder Wood River Capital sold about 12.28 million shares for roughly $58.1 million.
  • MarketBeat previews top five stocks to own in December.

Aspen Aerogels, Inc. (NYSE:ASPN - Get Free Report) shares passed below its 200-day moving average during trading on Friday. The stock has a 200-day moving average of $4.79 and traded as low as $4.43. Aspen Aerogels shares last traded at $4.4750, with a volume of 1,647,456 shares changing hands.

Wall Street Analysts Forecast Growth

A number of research analysts have recently weighed in on the stock. Weiss Ratings reissued a "sell (d-)" rating on shares of Aspen Aerogels in a research report on Monday, September 21st. Barclays boosted their price target on shares of Aspen Aerogels from $4.00 to $5.00 and gave the stock an "underweight" rating in a research note on Tuesday, August 11th. Roth Capital reaffirmed a "buy" rating and issued a $7.75 target price on shares of Aspen Aerogels in a research note on Friday, August 7th. Wall Street Zen upgraded Aspen Aerogels from a "sell" rating to a "hold" rating in a report on Saturday, October 31st. Finally, B. Riley Financial restated a "buy" rating on shares of Aspen Aerogels in a research report on Friday, August 7th. Three research analysts have rated the stock with a Buy rating, one has given a Hold rating and two have given a Sell rating to the company's stock. According to MarketBeat, the stock currently has an average rating of "Hold" and a consensus price target of $6.25.

Check Out Our Latest Research Report on ASPN

Aspen Aerogels Price Performance

The stock has a market capitalization of $372.01 million, a P/E ratio of -2.83 and a beta of 3.06. The company has a debt-to-equity ratio of 0.35, a quick ratio of 1.86 and a current ratio of 2.10. The firm has a fifty day moving average price of $5.33 and a two-hundred day moving average price of $4.79.

Aspen Aerogels (NYSE:ASPN - Get Free Report) last issued its quarterly earnings results on Thursday, November 5th. The construction company reported $0.11 earnings per share for the quarter, topping the consensus estimate of ($0.09) by $0.20. The business had revenue of $85.18 million for the quarter, compared to analysts' expectations of $72.07 million. Aspen Aerogels had a negative net margin of 60.81% and a negative return on equity of 28.86%. As a group, analysts expect that Aspen Aerogels, Inc. will post -0.72 EPS for the current fiscal year.

Insider Transactions at Aspen Aerogels

In related news, major shareholder Wood River Capital, Llc sold 12,280,426 shares of Aspen Aerogels stock in a transaction that occurred on Wednesday, September 23rd. The stock was sold at an average price of $4.73, for a total transaction of $58,086,414.98. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Company insiders own 2.96% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the business. BlackRock Inc. purchased a new stake in shares of Aspen Aerogels during the 2nd quarter valued at about $33,457,000. Palogic Value Management L.P. acquired a new position in shares of Aspen Aerogels during the second quarter worth $1,177,000. Deutsche Bank AG purchased a new stake in shares of Aspen Aerogels during the second quarter worth about $2,359,000. Baird Financial Group Inc. purchased a new position in Aspen Aerogels during the 2nd quarter worth approximately $2,189,000. Finally, George Kaiser Family Foundation purchased a new position in Aspen Aerogels in the second quarter valued at $20,081,000. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

(Get Free Report)

Aspen Aerogels is a materials technology company that develops and manufactures insulation products based on silica aerogel, a lightweight material known for its insulating properties. Founded in 2001, the company is headquartered in Northborough, Massachusetts. Its products include Pyrogel and Cryogel insulation for industrial and energy applications, Spaceloft insulation for buildings, and PyroThin thermal barriers designed to help manage heat in electric vehicle battery systems. These materials are used in areas such as energy infrastructure, building efficiency, and transportation.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Aspen Aerogels Right Now?

Before you consider Aspen Aerogels, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.

While Aspen Aerogels currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Forget Nvidia, Meta, and Google. Here's The New Magnificent Seven. Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines